CVS Health to split pharmacy business from insurance arm, reversing 2018 Aetna merger

CVS Health said it will split into two publicly traded companies, separating its roughly 9,000 retail pharmacy locations from its insurance and pharmacy benefit manager businesses. The separation is expected to be completed by the first half of 2028. Chief Executive David Joyner told The Wall Street Journal that the businesses are best served by splitting, given how they are performing. The plan reverses the 2018 deal that combined insurer Aetna and the retail chain into a $117 billion healthcare conglomerate. Existing shareholders will receive shares in both companies tax-free, according to the company, and CVS shares fell nearly 13% on Tuesday to levels not seen since spring.

Fox Business, the right-leaning outlet, leads with the consumer angle, featuring Douglas Hoey of the National Community Pharmacists Association, who told Fox News Digital the split could improve competition and lower costs, and could create a more level playing field for independent pharmacies. It also highlights the share drop and lists which units go into each company. Left-leaning CNN and The New York Times frame the move as the end of an era of consolidation, with CNN calling it one of the largest shakeups in healthcare and the Times headlining it as the end of a bigger-is-better era. Their excerpts focus on the deal's history rather than the stock drop or independent pharmacies. Alternative sources CNBC and Semafor add analyst and regulatory context: CNBC quotes Jefferies and Leerink analysts saying retail can now stand on its own economically, and Semafor notes growing scrutiny as Democrats regain Congress in January. All sides report the same basic plan and differ mainly on whether they stress consumer benefits or industry consolidation.